- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07017361
ERAS Program for Minimally Invasive Pancreatic Surgery: Comparing New vs. Traditional Recovery Methods
This important clinical trial compares two different approaches to recovery after minimally invasive pancreatoduodenectomy (removal of part of the pancreas and small intestine). The study will help determine whether a newer, enhanced recovery program (called ERAS) works better than traditional recovery methods for patients undergoing this complex pancreatic surgery.
What is being studied?
The research team wants to know if the ERAS (Enhanced Recovery After Surgery) program helps patients recover faster and with fewer complications compared to standard care. The ERAS group will receive special pre-surgery nutrition, optimized pain management, and earlier eating after surgery. The conventional group will follow typical hospital recovery protocols.
Who can participate?
- Adults (19+) scheduled for minimally invasive pancreatic surgery
- Generally in good health with good physical function
- Willing and able to complete study questionnaires
What does the study involve?
Participants will be randomly assigned to either the ERAS program or conventional care. The main things researchers will measure include:
- How many patients are ready to go home by day 5 after surgery
- Total hospital stay length
- Serious complications within 30 days
- Treatment costs
Why is this research important?
Pancreatic surgery is major operation with significant recovery challenges. Finding ways to help patients heal faster with fewer complications could greatly improve quality of life and reduce healthcare costs. The ERAS approach has shown promise in other types of surgery, but needs proper testing for pancreatic procedures.
General considerations about pancreatic surgery research
Minimally invasive techniques have revolutionized pancreatic surgery in recent years, allowing smaller incisions and potentially faster recovery. However, optimal recovery protocols are still being developed. This study represents an important step in determining the best ways to care for patients after these complex operations. The results could help establish new standards of care that benefit future patients nationwide.
For patients facing pancreatic surgery, understanding recovery expectations is crucial. Research like this helps provide evidence-based approaches to pain management, nutrition, and hospital stay duration. The comparison of costs is particularly valuable as healthcare systems seek to provide high quality care efficiently.
The study's focus on measurable discharge criteria represents an important shift toward objective recovery standards rather than arbitrary hospital stay lengths. This patient-centered approach acknowledges that recovery continues at home and aims to support patients through this transition while maintaining safety.
As pancreatic surgery techniques continue advancing, parallel improvements in recovery protocols are equally important. This research bridges that gap by systematically evaluating comprehensive recovery programs specifically designed for minimally invasive pancreatic procedures.
Upcoming Clinical Trials
-
NCT07935395Not yet recruiting
-
NCT07935252Not yet recruitingAcute and Chronic Postsurgical Pain
-
NCT07870876RecruitingVascular Access | Vascular Access Complication | Vascular Access Devices
-
NCT07936006RecruitingHypoxia | Caffeine | Placebo - Control
-
NCT07936461RecruitingFeasibility of Occupation-Based Immersive Virtual Reality for Upper-Limb Rehabilitation After StrokeStroke | Upper Extremity Paresis
-
NCT07935161Not yet recruitingPreterm Prelabor Rupture of Membranes (PPROM)
-
NCT07934602Not yet recruiting
-
NCT07936110RecruitingYoung Adult | Chronic Ankle Instability, CAI
-
NCT07901374Not yet recruitingKnee Osteoarthritis | Chronic Knee Pain
-
NCT07935278RecruitingMild Traumatic Brain Injury | Concussion (Diagnosis)
-
NCT07934745Not yet recruiting